Enzyme Deletion Prevents Fatal Lung Bleeding and Boosts Repair
Removing a key immune kinase reprograms regulatory T cells to heal damaged lung barriers and suppress systemic inflammation.
Removing a single immune enzyme prevents life-threatening lung bleeding in mice and reprograms specialized guardian cells to repair damaged tissue, a study reveals.
Pulmonary hemorrhage is a severe and often fatal complication of autoimmune diseases where the delicate barrier between air sacs and blood vessels in the lungs breaks down. Traditional treatments rely on heavy immunosuppression, yet mortality rates remain stubbornly high. Now, researchers have identified a potential molecular switch that not only halts this destructive inflammation, but actively drives tissue repair. The findings were published in eLife by Mohammad Saddam Hossain and colleagues.
How Eliminating an Enzyme Protects the Lungs
The team focused on interleukin-2-inducible T-cell kinase, an enzyme known to amplify immune responses and drive inflammation. By testing mice genetically lacking this enzyme, the researchers discovered that the animals were nearly completely protected against chemically induced pulmonary hemorrhage. While untreated control animals suffered massive blood accumulation in their lungs and lost architectural integrity, the modified mice maintained healthy tissue structures and showed greatly improved survival.

Further analysis revealed that the absence of the enzyme dramatically reshaped the animals’ immune landscapes. The lungs of the protected mice showed significantly fewer destructive inflammatory monocytes and neutrophils. Additionally, systemic inflammation dropped sharply, with circulating levels of harmful inflammatory cytokines like interferon-gamma, tumor necrosis factor-alpha, interleukin-6, and interleukin-17 all registering much lower.
Why Guardian T Cells Shift Into Repair Mode
The protective effect was not merely a passive lack of inflammation, but an active shift toward healing driven by regulatory T cells, specialized white blood cells that maintain immune tolerance. Mice lacking the enzyme exhibited a marked expansion of these regulatory populations in both the spleen and the lungs. When these specialized cells were isolated and transferred into diseased wild-type mice, they successfully rescued the animals from lung hemorrhage and restored baseline renal function.

Transcriptomic sequencing revealed that removing the enzyme reprogrammed the regulatory cells to be metabolically and functionally enhanced. These enhanced guardian cells expressed significantly higher levels of amphiregulin, a growth factor protein vital for tissue repair and barrier restoration. At the same time, the cells boosted production of anti-inflammatory signaling molecules like interleukin-10, creating a robust healing environment.
What These Discoveries Mean for Future Therapies
While the study demonstrates remarkable protection in a murine model, researchers note that experiments were conducted using germline-deficient animals and cells isolated from unchallenged subjects. Additional investigations using conditional genetic models will be necessary to pinpoint the exact cell-intrinsic pathways at play. Nevertheless, the work points to the enzyme as a promising therapeutic target for treating severe inflammatory lung conditions and systemic autoimmunity without shutting down the entire immune system.
The research was published in eLife on November 17, 2026.
This article has been fact checked for accuracy, with information verified against reputable sources. Learn more about us and our editorial process.
Last reviewed on .
Article history
- Latest version
Reference(s)
- Hossain, Mohammad Saddam., et al. “ITK deficiency protects against autoimmune pulmonary hemorrhage in mice by promoting amphiregulin-producing regulatory T cells.” eLife, vol. 15, November 17, 2026 eLife Sciences Publications, Ltd, doi: 10.7554/eLife.111915. <https://doi.org/10.7554/eLife.111915>.
Cite this page:
- Posted by Hassan Raza